Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Wednesday, 31 January 2018

US Market Report Suite for Laparoscopic Devices 2017 - Unit Sales, ASPs, Market Value & Growth Trends

 
US Market Report Suite for Laparoscopic Devices 2017 - Unit Sales, ASPs, Market Value & Growth Trends
DUBLIN, Jan. 31, 2018 /PRNewswire/ -- The "US Market Report Suite for Laparoscopic Devices 2017 - MedSuite" report has been added to ResearchAndMarkets.com's offering. General Report Contents Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends...
Read more

United States Immunology Drugs Market Report 2017
DUBLIN, Jan. 31, 2018 /PRNewswire/ -- The "United States Market Report Suite for Immunology Drugs 2017 - MedSuite" report has been added to ResearchAndMarkets.com's offering. Besides the typical market data found above you will be able to discover how these diseases have been...
Read more

European Orthopedic Trauma Devices Market 2017-2023 - Unit Sales, ASPs, Market Value & Growth Trends
DUBLIN, Jan. 31, 2018 /PRNewswire/ -- The "Orthopedic Trauma Devices Market Report Suite for Europe 2017-2023 - MedSuite" report has been added to ResearchAndMarkets.com's offering. General Report Contents Market Analyses include: Unit Sales, ASPs, Market Value &...
Read more

$28.5 Billion Titanium Dioxide (TiO2) Market, 2025
DUBLIN, Jan. 31, 2018 /PRNewswire/ -- The "Titanium Dioxide (TiO2) Market Analysis By Application (Paints & Coatings, Plastics, Paper & Pulp, Cosmetics), By Region (North America, Europe, Asia Pacific, CSA, MEA), And Segment Forecasts, 2014 - 2025" report has been added to...
Read more

Alkermes Submits New Drug Application To U.S. FDA For ALKS 5461 For The Adjunctive Treatment Of Major Depressive Disorder
- New Medicine for Treating Major Depressive Disorder Supported by Comprehensive Efficacy and Safety Data Package From More Than 1,500 Patients - DUBLIN, Jan. 31, 2018 /PRNewswire/ -- Alkermes plc (NASDAQ: ALKS) today announced that it has submitted a New Drug Application (NDA) to the...
Read more

A new publication confirms AZTherapies's innovative drug combination approach to address the neuroinflammation response via neuro-immunology and amyloid beta accumulation associated with neurodegeneration and Alzheimer's disease.
BOSTON, Jan. 31, 2018 /PRNewswire/ -- AZTherapies, Inc. is a privately held advanced clinical stage pharmaceutical company located in Boston, MA that is developing breakthrough treatments for Alzheimer's disease (AD), ischemic stroke, and other neurological diseases associated with...
Read more

Angostura® Global Cocktail Challenge 2018 Set for Carnival Sunday
PORT OF SPAIN, Trinidad and Tobago, Jan. 31, 2018 /PRNewswire/ -- The Angostura® Global Cocktail Challenge 2018 competition, which takes place on February 11th, 2018, at the House of Angostura, will see eleven (11) gifted bartenders demonstrate their inventiveness and skill as they find...
Read more